Tuberculin PPD Kit
Tuberculin PPD Kit
Authorised
- TUBERCULIN PURIFIED PROTEIN DERIVATIVE, AVIAN
- TUBERCULIN PURIFIED PROTEIN DERIVATIVE, BOVINE
Product identification
Medicine name:
Tuberculin PPD Kit
TUBERCULIN PPD KIT
Active substance:
- TUBERCULIN PURIFIED PROTEIN DERIVATIVE, AVIAN
- TUBERCULIN PURIFIED PROTEIN DERIVATIVE, BOVINE
Target species:
-
Cattle
Route of administration:
-
Intradermal use
Product details
Active substance and strength:
-
TUBERCULIN PURIFIED PROTEIN DERIVATIVE, AVIAN25000.00/international unit(s)0.10millilitre(s)
-
TUBERCULIN PURIFIED PROTEIN DERIVATIVE, BOVINE30000.00/international unit(s)0.10millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intradermal use
-
Cattle
-
Milkno withdrawal periodzero days
-
Meat and offalno withdrawal periodzero days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AR01
- QI02AR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Package description:
- The 50-doses presentation of the Tuberculin PPD Kit: Polystyrene box with 10 vials (hydrolytic Type I) of Bovine Tuberculin PPD 3000 and 10 vials (hydrolytic Type I) of Avian Tuberculin PPD 2500. Each vial contains 50 doses of 0.1 ml.
- The 20-doses presentation of the Tuberculin PPD Kit: Polystyrene box with 20 vials (hydrolytic Type I) of Bovine Tuberculin PPD 3000 and 20 vials (hydrolytic Type I) of Avian Tuberculin PPD 2500. Each vial contains 20 doses of 0.1 ml.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Prionics Lelystad B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Prionics Lelystad B.V.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/1007311 1/2021
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0322/001
Concerned member states:
-
France
-
Hungary
-
Ireland
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
English (PDF)
Download Published on: 13/06/2022
Summary of Product Characteristics
English (PDF)
Download Published on: 13/06/2022
French (PDF)
Published on: 10/10/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 10/10/2025